A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F10%3A33116044" target="_blank" >RIV/61989592:15110/10:33116044 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/10:7949 RIV/00843989:_____/12:00103097
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Original language description
Oral fingolimod, a sphingosine-1-phosphate-receptor modulator that prevents the egress of lymphocytes from lymph nodes, significantly improved relapse rates and end points measured on magnetic resonance imaging (MRI), as compared with either placebo or intramuscular interferon beta-1a, in phase 2 and 3 studies of multiple sclerosis
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FH - Neurology, neuro-surgery, nuero-sciences
OECD FORD branch
—
Result continuities
Project
—
Continuities
S - Specificky vyzkum na vysokych skolach
Others
Publication year
2010
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The new England Journal Medicine
ISSN
0028-4793
e-ISSN
—
Volume of the periodical
362
Issue of the periodical within the volume
5
Country of publishing house
GB - UNITED KINGDOM
Number of pages
14
Pages from-to
387-401
UT code for WoS article
—
EID of the result in the Scopus database
—